CHJTF Stock CSPC Pharmaceuticals Group (CHJTF, $0.95) dropped -25.38% over the last 3 months
at Tickeron.com
Loading...
CSPC Pharmaceuticals Group (CHJTF, $0.95) lost -2 over the last three months. By comparison, the broader Pharmaceuticals: Major Industry returned over the same period. A.I.dvisor analyzed 62 stocks in the Pharmaceuticals: Major Industry over the last three months, and found that of them (6) exhibited an Uptrend while of them (3) experienced a Downtrend.
CHJTF in upward trend: price may ascend as a result of having broken its lower Bollinger Band on November 24, 2025
CHJTF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 9 cases where CHJTF's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 26, 2025. You may want to consider a long position or call options on CHJTF as a result. In of 30 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for CHJTF just turned positive on November 04, 2025. Looking at past instances where CHJTF's MACD turned positive, the stock continued to rise in of 25 cases over the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Aroon Indicator for CHJTF entered a downward trend on November 20, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.311) is normal, around the industry mean (8.915). P/E Ratio (19.992) is within average values for comparable stocks, (23.825). Projected Growth (PEG Ratio) (1.282) is also within normal values, averaging (2.041). Dividend Yield (0.032) settles around the average of (0.026) among similar stocks. P/S Ratio (2.985) is also within normal values, averaging (3.624).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CHJTF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHJTF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock worse than average.
Advertisement
General Information
Industry PharmaceuticalsMajor